Skip to main content
Log in

Le somatomedine. Significato e prospettive

  • Published:
Acta diabetologia latina Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Bibliografia

  1. Alford F. P., Bellair J. T., Burger H. G., Lovett N.: A Simplified Assay for Somatomedin — J. Endocr.54, 365, 1972.

    PubMed  CAS  Google Scholar 

  2. Almqvist S.: Studies on Sulfation Factor (SF) Activity of Human Serum. Effect of Human Growth Hormone on SF Levels in Pituitary Dwarfism — Acta endocr. (Kbh.)35, 381, 1960.

    CAS  Google Scholar 

  3. Almqvist S.: Studies of Sulfation Factor (SF) Activity of Human Serum. Evaluation of an Improved Method for the in Vitro Bioassay of SF and the Effect of Glutamine and Human Growth Hormone in the System — Acta endocr. (Kbh.)36, 31, 1961.

    CAS  Google Scholar 

  4. Almqvist S., Falkheden T.: Studies on Sulfation Factor (SF) Activity of Human Serum. Rate of Decrease of Serum SF after Hypophysectomy — Acta endocr. (Kbh.)37, 315, 1961.

    CAS  Google Scholar 

  5. Almqvist S., Rune I.: Studies on Sulfation Factor (SF) Activity of Human Serum. The Variation of SF with Age — Acta endocr. (Kbh.)36, 566, 1961.

    CAS  Google Scholar 

  6. Baumann G., Cain J. P., Dingmann J. F.: Gigantism with Hypopituitarism — Amer. med. J.53, 805, 1972.

    CAS  Google Scholar 

  7. Beck J. C., Gonda A., Hamid M. A., Morgan R. D., Rubinstein D., McGarry R. E.: Some Metabolic Changes Induced by Primate Growth Hormone and Purified Ovine Prolactin — Metabolism13, 1108, 1964.

    PubMed  CAS  Google Scholar 

  8. Bonati B., Della Casa R., Marrama P., Ventura E.: Somatotropo ed epatopatie croniche — Atti 13° Congr. Soc. Ital. Endocr. Roma 1970. Edizioni Medico-Scientifiche, Torino, 1970; p. 79.

    Google Scholar 

  9. Bostrom H., Jorpes E., Mansson B., Roden L., Vestermark A.: On the Partial Purification of a Liver Factor Stimulating the Sulphate Exchange of Chondroitinsulphuric Acid — Ark. Kem.8, 469, 1955.

    CAS  Google Scholar 

  10. Brasel J. A., Wright J. C., Wilkins L., Blizzard R. M.: An Evaluation of Seventy-Five Patients with Hypopituitarism Beginning in Childhood — Amer. J. Med.38, 484, 1965.

    PubMed  CAS  Google Scholar 

  11. Bürgi H., Müller W. A., Humbel R. E., Froesch E. R.: Purification of Plasma Protein with Non-Suppressible Insulin-Like Activity — Diabetologia1, 77, 1965.

    Google Scholar 

  12. Bürgi H., Müller W. A., Humbel R. E., Labhart A., Froesch E. R.: Non-Suppressible Insulin-Like Activity of Human Serum. I. Physicochemical Properties, Extraction and Partial Purification — Biochim. biophys. Acta (Amst.)121, 349, 1966.

    Google Scholar 

  13. Buxtorf U.: Non-Suppressible Insulin-Like Activity of Human Serum. IV. Effects of Purified Non-Suppressible Insulin-Like Activity and of Insulin on Protein Synthesis of Adipose Tissue from (14C)-Glucose, (14C)-Pyruvate and (14C)-Glycine — Biochim. biophys. Acta (Amst.)177, 512, 1969.

    CAS  Google Scholar 

  14. Cohen S.: Isolation of a Mouse Submaxillary Gland Protein Accelerating Incisor Eruption and Eyelid Opening in the Newborn Animal — J. biol. Chem.237, 1555, 1962.

    PubMed  CAS  Google Scholar 

  15. Cuatrecasas P.: Interaction of Insulin with the Cell Membrane: the Primary Action of Insulin — Proc. nat. Acad. Sci. (Wash.)63, 450, 1969.

    CAS  Google Scholar 

  16. Cuatrecasas P.: Insulin-Receptor Interactions in Adipose Tissue Cells: Direct Measurement and Properties — Proc. nat. Acad. Sci. (Wash.)68, 1264, 1971.

    CAS  Google Scholar 

  17. Daughaday W. H.: Sulfation Factor Regulation of Skeletal Growth. A Stable Mechanism Dependent on Intermittent Growth Hormone Secretion — Amer. J. Med.50, 277, 1971.

    PubMed  CAS  Google Scholar 

  18. Daughaday W. H.: The Sulfation Factor: Hypothesis: Recent Observations — In:Pecile A., Müller E. E. (Eds): Growth and Growth Hormone. Excerpta Medica Foundation, Amsterdam, 1972; p. 168.

    Google Scholar 

  19. Daughaday W. H.: Regulation of Skeletal Growth by Sulfation Factor — Advanc. intern. Med.17, 237, 1971.

    CAS  Google Scholar 

  20. Daughaday W. H., Garland J. T.: citato inGourmelen e Coll.48.

    Google Scholar 

  21. Daughaday W. H., Hall K., Raben M. S., Salmon W. D. Jr., van den Brande J. L., van Wyk J. J.: Somatomedin: a Proposed Designation for the ‘Sulphation Factor’ — Nature (Lond.)235, 107, 1972.

    CAS  Google Scholar 

  22. Daughaday W. H., Heinz J. N., Srivastava L., Hammer C.: Sulfation Factor: Studies of its Removal from Plasma and Metabolic Fate in Cartilage — J. Lab. clin. Med.72, 803, 1968.

    PubMed  CAS  Google Scholar 

  23. Daughaday W. H., Mariz J. K.: Conversion of Proline-U-C14 to Labeled Hydroxyproline by Rat Cartilage in Vitro: Effects of Hypophysectomy, Growth Hormone, and Cortisol — J. Lab. clin. Med.59, 741, 1972.

    Google Scholar 

  24. Daughaday W. H., Reeder C.: Synchronous Activation of DNA Synthesis in Hypophysectomized Rat Cartilage by Growth Hormone — J. Lab. clin. Med.68, 357, 1966.

    PubMed  CAS  Google Scholar 

  25. Daughaday W. H., Salmon W. D. Jr., Alexander F.: The Measurement of Serum Sulfation Factor as an Index of Somatotropin Activity in Man — J. clin. Invest.37, 888, 1958.

    Google Scholar 

  26. Daughaday W. H., Salmon W. D. Jr., Alexander F.: Sulfation Factor Activity of Sera from Patients with Pituitary Disorders — J. clin. Endocr.19, 743, 1959.

    PubMed  CAS  Google Scholar 

  27. Ellis S., Huble J., Simpson M. E.: Influence of Hypophysectomy and Growth Hormone on Cartilage Sulfate Metabolism — Proc. Soc. exp. Biol. (N. Y.)84, 603, 1953.

    CAS  Google Scholar 

  28. Finkelstein J. W., Kream J., Ludan A., Hellman L.: Sulfation Factor (Somatomedin): an Explanation for Continued Growth in the Absence of Immunoassayable Growth Hormone in Patients with Hypothalamic Tumors — J. clin. Endocr.35, 13, 1972.

    PubMed  CAS  Google Scholar 

  29. Finkelstein J. W., Roffwarg H. D., Boyar R. M., Kream J., Hellman L.: Age Related Change in 24 Hour Secretion of Growth Hormone — J. clin. Endocr.35, 665, 1972.

    PubMed  CAS  Google Scholar 

  30. Franchimont P.: Sécrétion normale et pathologique de la somatotrophine et des gonadotrophines humaines — Masson et Cie Éd., Paris, 1971.

    Google Scholar 

  31. Fraster S. D., Smith F. G. Jr.: Return of Normal Growth Following Removal of a Craniopharyngioma — Amer. J. Dis. Child.116, 311, 1968.

    Google Scholar 

  32. Frazier W. A., Angeletti R. H., Bradshaw R. A.: Nerve Growth Factor and Insulin. Structural Similarities Indicate an Evolutionary Relationship Reflected by Physiological Action — Science176, 482, 1972.

    PubMed  CAS  Google Scholar 

  33. Froesch E. R., Bürgi H., Müller W. A., Humbel R. E., Jakob A., Labhart A.: Nonsuppressible Insulin-Like Activity of Human Serum: Purification, Physiochemical and Biological Properties and its Relation to Total Serum ILA — Recent. Progr. Hormone Res.23, 565, 1967.

    PubMed  CAS  Google Scholar 

  34. Froesch E. R., Bürgi H., Ramseir E. B., Bally P., Labhart A.: Antibody-Suppressible and Nonsuppressible Insulin-Like Activities in Human Serum and Their Physiologic Significance. An Insulin Assay with Adipose Tissue of Increased Precision and Specificity — J. clin. Invest.42, 1816, 1963.

    PubMed  CAS  Google Scholar 

  35. Froesch E. R., Morel B., Zapf J., Zingg A. E., Meuli C., Schlumpf U., Heimann R., Eigenmann E., Humbel R. E.: NSILA-S: Insulin-Like Properties, Receptor Binding Activities and Relationship to Somatomedin — Acta endocr. (Kbh.)184 (Suppl.), 183, 1974.

    Google Scholar 

  36. Froesch E. R., Müller W. A., Bürgi H., Waldvogel M., Labhart A.: Nonsuppressible Insulin-Like Activity of Human Serum. II. Biological Properties of Plasma Extracts with Nonsuppressible Insulin-Like Activity — Biochim. biophys. Acta (Amst.)121, 360, 1966.

    CAS  Google Scholar 

  37. Garland J. T., Daughaday W. H.: Feedback Inhibition of Pituitary Growth Hormone in Rats Infested with Spirometra Mansonoides — Proc. Soc. exp. Biol. (N. Y.)139, 497, 1972.

    CAS  Google Scholar 

  38. Garland J. T., Lottes M. E., Kozak S., Daughaday W. H.: Stimulation of DNA Synthesis in Isolated Chondrocytes by Sulfation Factor — Endocrinology90, 1086, 1972.

    PubMed  CAS  Google Scholar 

  39. Garland J. T., Ruegamer W. R., Daughaday W. H.: Induction of Sulfation Factor Activity by Infection of Hypophysectomized Rats with Spirometra Mansonoides — Endocrinology88, 924, 1971.

    PubMed  CAS  Google Scholar 

  40. Geiger W.: The Way of HCG, HCS and STH into the Amniotic Fluid: Conclusions by their Dynamic Equilibrance and Renal Excretion — Acta endocr. (Kbh.)73 (Suppl. 177), 238, 1973.

    Google Scholar 

  41. Giordano G., Foppiani E., Minuto F., Marugo M., Comaschi M.: Obesità ed ormone somatotropo. II. Il comportamento della somatomedina in corso di obesità — Folia endocr. (Roma)27, 369, 1974.

    CAS  Google Scholar 

  42. Giordano G., Foppiani E., Minuto F., Perroni D.: Comportamento dell’ormone somatotropo e della somatomedina nei neonati — Congr. Endocr. Pediat., Genova 1974.

  43. Giordano G., Foppiani E., Minuto F., Perroni D.: Comportamento della somatomedina nei soggetti cirrotici — Boll. Soc. ital. Biol. sper. (in stampa).

  44. Giordano G., Marugo M., Minuto F., Barreca T.: Comportamento della secrezione dell’ormone somatotropo in corso di epatopatie croniche — Arch. E. Maragliano Pat. Clin.27, 175, 1971.

    CAS  Google Scholar 

  45. Giordano G., Marugo M., Minuto F., Barreca T.: Significato della somatotropinemia basale nell’uomo in condizioni normali e patologiche — Arch. E. Maragliano Pat. Clin.28, 73, 1972.

    CAS  Google Scholar 

  46. Giordano G., Minuto F., Foppiani E., Comaschi A.: Il dosaggio della somatomedina in soggetti normali e patologici Atti Giornate Endocrinologiche Pisane, Pisa 1973. Pacini Ed., Pisa, 1974; p. 324.

    Google Scholar 

  47. Giordano G., Minuto F., Foppiani E., Perroni D.: Il test dell’induzione somatomedinica con HGH nella diagnostica delle iposomie — Symp. Int. su «Il trattamento dei ritardi staturali», Fiuggi 1974.

  48. Gourmelen M., Mimouni M., Bastide M. H., Binoux M., Lestradet H.: Reprise Spontanée de la croissance au cours d’une insuffisance hypothalamo-hypophysaire — Ann. Pédiat.20, 646, 1973.

    Google Scholar 

  49. Grant D. B., Hambley J., Becker D., Pimstone B. L.: Reduced Sulfation Factor in Undernourished Children — Arch. Dis. Childh.48, 596, 1973.

    PubMed  CAS  Google Scholar 

  50. Grant D. B., Kaplan S. L., Grumbach M. M.: Studies on the Cross-Reaction between Human Growth Hormone and Human Chorionic Somatomammotropin in Radioimmunoassay Systems — J. clin. Endocr.32, 88, 1971.

    PubMed  CAS  Google Scholar 

  51. Greenspan F. S., Li C. H., Simpson M. E., Evans H. M.: Bioassay of Hypophyseal Growth Hormone: the Tibia Test — Endocrinology45, 455, 1949.

    PubMed  CAS  Google Scholar 

  52. Hall K.: Quantitative Determination of the Sulphation Factor Activity in Human Serum — Acta endocr. (Kbh.)63, 338, 1970.

    CAS  Google Scholar 

  53. Hall K.: Effect of Intravenous Administration of Human Growth Hormone on Sulphation Factor Activity in Serum of Hypopituitary Subjects — Acta endocr. (Kbh.)66, 491, 1971.

    CAS  Google Scholar 

  54. Hall K.: Human Somatomedin: Determination, Occurence, Biologic Activity and Purification — Acta endocr. (Kbh.)163 (Suppl.), 1972.

  55. Hall K., Holmgren A., Lindahl U.: Purification of a Sulphation Factor from Skeletal Muscle of Rat — Biochim. biophys. Acta (Amst.)201, 398, 1970.

    CAS  Google Scholar 

  56. Hall K., Olin P.: Sulphation Factor Activity and Growth Rate during Long-Term Treatment of Patients with Pituitary Dwarfism with Human Growth Hormone — Acta endocr. (Kbh.)69, 417, 1972.

    CAS  Google Scholar 

  57. Hall K., Uthne K.: Human Growth Hormone and Sulfation Factor — In:Pecile A., Müller E. E. (Eds): Growth and Growth Hormone. Excerpta Medica Foundation, Amsterdam, 1972; p. 192.

  58. Hall K., Uthne K.: Some Biological Properties of Purified Sulfation Factors (SF) from Human Plasma — Acta med. scand.190, 137, 1971.

    PubMed  CAS  Google Scholar 

  59. Hall K., van Wyk J. J.: Somatomedin — In:Martini L., James V. H. T. (Eds): Current Topics in Experimental Endocrinology. Academic Press, New York, 1974; p. 190.

    Google Scholar 

  60. Heinz J. N., Garland J. T., Daughaday W. H.: Incorporation of35S Sulfate into Rat Cartilage Explants in Vitro. Effects of Aging on Responsiveness to Stimulation by Sulfation Factor — Endocrinology87, 688, 1970.

    Google Scholar 

  61. Hintz R. L., Clemmons D. R., Underwood L. E., van Wyk J. J.: Competitive Binding of Somatomedin to the Insulin Receptor of Adipocytes, Condrocytes, and Liver Membranes — Proc. nat. Acad. Sci. (Wash.)69, 2351, 1972.

    CAS  Google Scholar 

  62. Holmes L. B., Frantz A. G., Rabkin M. T., Stuart-Soeldner J., Crawford J. D.: Normal Growth with Subnormal Growth-Hormone Levels — New Engl. J. Med.279, 559, 1968.

    PubMed  CAS  Google Scholar 

  63. Jakob A., Hauri Ch., Froesch E. R.: Nonsuppressible Insulin-Like Activity in Human Serum. III. Differentiation of Two Distinct Molecules with Nonsuppressible ILA — J. clin. Invest.47, 2678, 1968.

    PubMed  CAS  Google Scholar 

  64. Job J. C., Lambertz J., Sizonenko P., Rossier A.: La croissance des enfants atteints de craniopharyngiome. Vitesse de croissance et résultats des dosages d’hormone de croissance dans le plasma avant et après intervention chirurgicale — Arch. franç. Pédiat.27, 341, 1970.

    PubMed  CAS  Google Scholar 

  65. Kaplan S. L., Grumbach M. M.: Studies on Human and Simian Placental Hormone with Growth Hormone-Like and Prolactin-Like Activities — J. clin. Endocr.24, 80, 1964.

    PubMed  CAS  Google Scholar 

  66. Kenny F. M., Guyda H. J., Wright J. C., Friesen H. G.: Prolactin and Somatomedin in Hypopituitary Patients with ‘Catch-up’ Growth Following Operations for Craniopharyngioma — J. clin. Endocr.36, 378, 1973.

    PubMed  CAS  Google Scholar 

  67. Kenny F. M., Iturzaeta N. F., Mintz D., Brash A., Garces L., Susen A., Askari N. A.: Iatrogenic Hypopituitarism in Craniopharyngioma: Unexplained ‘Catch-up’ Growth in Three Children — J. Pediat.72, 766, 1968.

    PubMed  CAS  Google Scholar 

  68. Killifer F. A., Stein W. E.: Clinic Effect of Hypothalamic Injury — Arch. Neurol. (Chic.)22, 419, 1970.

    Google Scholar 

  69. Kostyo J. L., Nutting D. F.: Acute in Vivo Effects of GH on Protein Synthesis in Various Tissues of Hypophysectomized Rats and their Relationship to the Levels of Thymidine Factor and Insulin in the Plasma — Hormone metab. Res.5, 167, 1973.

    CAS  Google Scholar 

  70. Kostyo J. L., Uthne K., Reagan C. R., Gimpel L. P.: Comparison of the Effects of Growth Hormone and Somatomedin on Skeletal Muscle Metabolism — In:Raiti S. (Ed.): Advances in Human Growth Hormone Research. Symposium in Baltimore 9-12/10/1973. DHEW Publ., Washington, 1973; p. 127.

    Google Scholar 

  71. Laron Z., Pertzelan A., Karp M., Kowadlo-Silberfeld A., Daughaday W. H.: Administration of Growth Hormone to Patients with Familial Dwarfism with High Plasma Immunoreactive Growth Hormone: Measurement of Sulfation Factor, Metabolic and Linear Growth Responses — J. clin. Endocr.33, 332, 1971.

    PubMed  CAS  Google Scholar 

  72. Laron Z., Pertzelan A., Mannheimer S.: Genetic Pituitary Dwarfism with High Serum Concentration of HGH. A New Inborn Error of Metabolism — Israel J. Med. Sci.2, 152, 1966.

    PubMed  CAS  Google Scholar 

  73. Lyngsøe J.: Seruminsulin. A Review — Acta med. scand.279 (Suppl. 441), 1, 1965.

    Google Scholar 

  74. Marshall R. N., Underwood L. E., Voina S. J., Foushee D. B., van Wyk J. J.: Characterization of the Insulin- and Somatomedin-C Receptors in Human Placental Cell Membranes — J. clin. Endocr.39, 283, 1974.

    PubMed  CAS  Google Scholar 

  75. Matson D. D., Crigler J. F. Jr.: Management of a Craniopharyngioma in Childhood — J. Neurosurg.30, 377, 1969.

    PubMed  CAS  Google Scholar 

  76. McConaghey P.: The Production of ‘Sulphation Factor’ by Rat Liver — J. Endocr.52, 1, 1972.

    PubMed  CAS  Google Scholar 

  77. McConaghey P., Muller J.: Sulfation Factor: its Production by the Rat Liver and Kidney — 2nd Int. Symp. on Growth Hormone, Milano 1971. Excerpta Medica Foundation, Amsterdam, 1971; abstract # 46.

  78. McConaghey P., Sledge C. B.: Production of ‘Sulphation Factor’ by the Perfused Liver — Nature (Lond.)225, 1249, 1970.

    CAS  Google Scholar 

  79. Meade R. C., Klitgaard H.M., Holanders E.: Characteristics of Nonsuppressible Insulin-Like Activity in Fasting Human Serum — Diabetes21, 271, 1972.

    PubMed  CAS  Google Scholar 

  80. Mueller J. F., Reed P.: Growth Stimulation Induced by Infection with Spirometra Mansonoides Spargana in Propylthiouracil-Treated Rats — J. Parassit.54, 51, 1968.

    CAS  Google Scholar 

  81. Oelz O., Jakob A., Diem S., Froesch F. R.: Non-Suppressible Insulin-Like Activity in Human Serum. VI. Difference between the Action of Insulin and That of Precipitated Non-Suppressible Insulin-Like Activity on Glycogen Synthesis of Rat Adipose Tissue and Muscle — Biochim. biophys. Acta (Amst.)230, 20, 1971.

    CAS  Google Scholar 

  82. Pierson R. W. Jr., Temin H. M.: The Partial Purification from Calf Serum of a Fraction with Multiplication-Stimulating Activity for Chicken Fibroblasts in Cell Culture with Non-Suppressible Insulin-Like Activity — J. cell. Physiol.79, 319, 1972.

    PubMed  CAS  Google Scholar 

  83. Phillips L. S., Herington A. C., Daughaday W. H.: Hormone Effects on Somatomedin Action and Somatomedin Generation — In:Raiti S. (Ed.): Advances in Human Growth Hormone Research. Symposium in Baltimore 9-12/10/1973. DHEW Publ., Washington, 1974; p. 50.

    Google Scholar 

  84. Phillips L. S., Herington A. C., Müller M. C., Daughaday W. H.: Cortisol Inhibition of Growth Hormone-Induced Somatomedin (Sulfation Factor) Generation — Clin. Res.21, 68, 1973.

    Google Scholar 

  85. Poffenbarger P. L., Espinosa de los Monteros Mena A., Steinke J.: Non-suppressible Insulin-Like Activity: Immunochemical and Physicochemical Evidence against its Pancreatic Origin — Metabolism19, 509, 1970.

    PubMed  CAS  Google Scholar 

  86. Raben M. S.: Growth Hormone: Anabolic and Anticatabolic Agent — Diabetes14, 374, 1965.

    Google Scholar 

  87. Raben M. S., Murakawa S., Matute M.: Some Observations Concerning Serum ‘Thymidine Factor’ — In:Pecile A., Müller E. E. (Eds): Growth and Growth Hormone. Excerpta Medica Foundation, Amsterdam, 1972; p. 124.

    Google Scholar 

  88. Randle P. J.: Enhancement of Insulin Action by Pituitary Growth Hormone — Nature (Lond.)174, 1053, 1954.

    CAS  Google Scholar 

  89. Randle P. J.: Plasma-Insulin Activity in Acromegaly Assayed by Rat-Diaphragm Method. Preliminary Comunication — Lancet1, 441, 1954.

    Google Scholar 

  90. Randle P. J., Young F. G.: The Influence of Pituitary Growth Hormone on Plasma Insulin Activity — J. Endocr.13, 335, 1956.

    PubMed  CAS  Google Scholar 

  91. Rimoin D. L., Merimee T. J., Rabinowitz D., McKusick W. A.: Genetic Aspects of Clinical Endocrinology — Recent Progr. Hormone Res.24, 365, 1968.

    PubMed  CAS  Google Scholar 

  92. Rosenberg D., David L., Bertrand J., Ruitton-Ullengo Laras C., Picot C., Monnet P.: Craniopharyngiome. Reptise de croissance après l’intervention malgré le deficit en hormone somatotrope — Arch. franç. Pédiat.27, 335, 1970.

    Google Scholar 

  93. Ruegamer W. R.: citato inDaughaday 17.

    Google Scholar 

  94. Ruegamer W. R., Muller J. F.: Proc. Amer. Thyroid Ass. 1969; abstract # 65.

  95. Salmon W. D. Jr.: Investigation with a Partially Purified Preparation of Serum Sulfation Factor: Lack of Specificity for Cartilage Sulfation — In:Pecile A., Müller E. E. (Eds): Growth and Growth Hormone. Excerpta Medica Foundation, Amsterdam, 1972; p. 180.

    Google Scholar 

  96. Salmon W. D. Jr.: Effects of Somatomedin on Cartilage Metabolism: Further Observations on an Inhibiting Serum Factor — In:Raiti S. (Ed.): Advances in Human Growth Hormone Research. Symposium in Baltimore 9-12/10/1973. DHEW Publ., Washington, 1974; p. 76.

    Google Scholar 

  97. Salmon W. D. Jr., Daughaday W. H.: A Hormonally Controlled Serum Factor which Stimulates Sulfate Incorporation by Cartilage in Vitro — J. Lab. clin. Med.49, 825, 1957.

    PubMed  CAS  Google Scholar 

  98. Salmon W. D. Jr., Duvall M. R.: A Serum Fraction with ‘Sulfation Factor Activity’ Stimulates in Vitro Incorporation of Leucine and Sulfate into Protein-Polysaccharide Complexes, Uridine into RNA and Thymidine into DNA of Costal Cartilage from Hypophysectomized Rats — Endocrinology86, 721, 1970.

    PubMed  CAS  Google Scholar 

  99. Salmon W. D. Jr., Duvall M. R.: In Vitro Stimulation of Leucine Incorporation into Muscle and Cartilage Protein by a Serum Fraction with Sulfation Factor Activity: Differentiation of Effects from Those of Growth Hormone and Insulin — Endocrinology87, 1168, 1970.

    PubMed  CAS  Google Scholar 

  100. Salmon W. D. Jr., Hosse B. R.: Stimulation of HeLa Cell Growth by a Serum Fraction with Sulfation Factor Activity — Proc. Soc. exp. Biol. (N. Y.)136, 805, 1971.

    CAS  Google Scholar 

  101. Schoeffling K., Ditschuneit H., Petzoldt R., Beyer J., Pfeiffer E. F., Sirek A., Geerling H., Sirek O. V.: Serum Insulin-Like Activity in Hypophysectomized and Pancreatectomized (Houssay) Dogs — Diabetes14, 658, 1965.

    PubMed  CAS  Google Scholar 

  102. Snipes C. A.: Effects of Growth Hormone and Insulin on Aminoacid and Protein Metabolism — Quart. Rev. Biol.43, 127, 1968.

    Google Scholar 

  103. Steelman L. S., Glitzer M. S., Ostlind D. A., Mueller J. F.: Biological Properties of the Growth Hormone-Like Factor from the Pletocercoid of ‘Spirometra Mansonoides’ — Recent Progr. Hormone Res.22, 97, 1971.

    Google Scholar 

  104. Steelman L. S., Morgan E. R., Cuccaro A. J., Glitzer M. S.: Growth Hormone-Like Activity in Hypophysectomized Rats Implanted with Spirometra Mansonoides Spargana — Proc. Soc. exp. Biol. (N. Y.)133, 269, 1970.

    CAS  Google Scholar 

  105. Tanner J. M.: Human Growth Hormone — Nature (Lond.)237, 433, 1972.

    CAS  Google Scholar 

  106. Taylor J. M., Mitchell W. M., Cohen S.: Epidermal Growth Factor. Physical and Chemical Properties — J. biol. Chem.247, 5928, 1972.

    PubMed  CAS  Google Scholar 

  107. Underwood L. E., Hintz R. L., Voina S. J., van Wyk J. J.: Human Somatomedin, the Growth Hormone Dependent Sulfation Factor, Is Anti-Lipolytic — J. clin. Endocr.35, 194, 1972.

    PubMed  CAS  Google Scholar 

  108. Uthne K.: Human Somatomedins: Purification and Some Studies on Their Biological Actions — Acta endocr. (Kbh.)175 (Suppl.), 1973.

  109. Uthne K., Hall K.: Somatomedin Purification and Biological Action in Vitro — Acta endocr. (Kbh.)177 (Suppl.), 202, 1973.

    Google Scholar 

  110. Uthne K., Kostyo J. C., Reagan C. R., Gimpel P. L.: Effect of Somatomedin (SF) on Transport and Incorporation of Sugar and Aminoacid in Rat Muscle — Acta endocr. (Khb.)177 (Suppl.), 203, 1973.

    Google Scholar 

  111. Uthne K., Westermark B., Wasteson A.: Purification on Somatomedin from Human Plasma Stimulating DNA Synthesis in Human Glia-Like Cells — J. cell. comp. Physiol. 1973 (in stampa).

  112. van den Brande J. L., du Caju M. V. L.: Plasma Somatomedin Activity in Children with Growth Disturbances — In:Raiti S. (Ed.): Advances in Human Growth Hormone Research. Symposium in Baltimore 9-12/10/1973. DHEW Publ., Washington, 1974; p. 98.

    Google Scholar 

  113. van den Brande J. L., du Caju M. V. L.: An Improved Technique for Measuring Somatomedin Activity in Vitro — Acta endocr. (Kbh.)75, 233, 1974.

    Google Scholar 

  114. van den Brande J. L., Kootte K., Tielenburg R., van der Wilk M., Huyser T.: Studies of Plasma Somatomedin Activity in Different Animal Species — Acta endocr. (Kbh.)75, 243, 1974.

    Google Scholar 

  115. van den Brande J. L., Kootte E. F., Tielenburg R., van der Wilk M., Koot T.: Plasma Sulfation Factor in Different Animal Species — 2nd Int. Symp. on Growth Hormone, Milano 1971. Excerpta Medica Foundation, Amsterdam, 1971; abstract # 47.

    Google Scholar 

  116. van den Brande J. L., van Wyk J. J., Weaver R. P., Mayberry H. E.: Partial Characterization of Sulphation and Thymidine Factors in Acromegalic Plasma — Acta endocr. (Kbh.)66, 65, 1971.

    Google Scholar 

  117. van Wyk J. J., Hall K., van den Brande J. L., Weaver R. P.: Further Purification and Characterization of Sulfation Factor and Thymidine Factor from Acromegalic Plasma — J. clin. Endocr.32, 389, 1971.

    PubMed  Google Scholar 

  118. van Wyk J. J., Hall K., van den Brande J. L., Weaver R. P., Uthne K., Hintz R. L., Harrison J. H., Mathewson P.: Partial Purification from Human Plasma of a Small Peptide with Sulfation Factor and Thymidine Factor Activities — In:Pecile A., Müller E. E. (Eds): Growth and Growth Hormone. Excerpta Medica Foundation, Amsterdam, 1972; p. 155.

    Google Scholar 

  119. van Wyk J. J., Hall K., Weaver R. P.: Partial Purification and Characterization of Sulphation and Thymidine Factor from Plasma — Biochim. biophys. Acta (Amst.)192, 560, 1969.

    Google Scholar 

  120. van Wyk J. J., Hintz R. L., Clemmons D. R., Hall K., Uthne K.: Human Somatomedin, the Growth Hormone Dependent Sulfation and Thymidine Factor — In:Scow R. (Ed.): Endocrinology. Excerpta Medica Foundation, Amsterdam, 1973; p. 642.

    Google Scholar 

  121. van Wyk J. J., Underwood L. E., Hintz R. L., Voina S. J., Weaver R. P.: Chemical Properties and Some Biological Effects of Human Somatomedin — In:Raiti S. (Ed.): Advances in Human Growth Hormone Research. Symposium in Baltimore 9-12/10/1973. DHEW Publ., Washington, 1974; p. 15.

    Google Scholar 

  122. van Wyk J. J., Underwood L. E., Hintz R. L., Voina S. J., Weaver R. P.: The Somatomedin: a Family of Insulin-Like Hormones under Growth Hormone Control — Recent Progr. Hormone Res. 1974 (in stampa).

  123. Varma S. K., Sönksen P. H., Varma K., Soeldner J. S., Selenkow H. A., Emerson K. J.: Measurement of Human Growth Hormone in Pregnancy and Correlation with Human Placental Lactogen — J. clin. Endocr.32, 328, 1971.

    PubMed  CAS  Google Scholar 

  124. Wiedemann E., Schwartz E.: Suppression of Growth Hormone-Dependent Human Serum Sulfation Factor by Estrogen — J. clin. Endocr.34, 51, 1972.

    PubMed  Google Scholar 

  125. Wright P. H.: Plasma-Insulin Activity in Acromegaly and Spontaneous Hypoglycaemia — Lancet1, 951, 1960.

    PubMed  CAS  Google Scholar 

  126. Yde H.: A Simplified Technique for the Determination of Growth Hormone Dependent Sulfation Factor, Using Intact Animals — Acta endocr. (Kbh.)57, 557, 1968.

    CAS  Google Scholar 

  127. Zahnd G. R., Steinke J., Renold A. E.: Early Metabolic Effects of Human Growth Hormone — Proc. Soc. exp. Biol. (N. Y.)105, 455, 1960.

    CAS  Google Scholar 

  128. Zimmerman T. S., White M. G., Daughaday W. H., Goetz F. G.: Hypopituitarism with Normal or Increased Height. Report of Two Cases, with Measurements of Plasma Growth Hormone Levels — Amer. J. Med.42, 146, 1967.

    PubMed  CAS  Google Scholar 

  129. Zingg A. E., Froesch E. R.: Effects of Partially Purified Preparations with Non-suppressible Insulin-Like Activity (NSILA-S) on Sulfate Incorporation into Rat and Chicken Cartilage — Diabetologia9, 472, 1973.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giordano, G. Le somatomedine. Significato e prospettive. Acta diabet. lat 12 (Suppl 1), 48–73 (1975). https://doi.org/10.1007/BF02581144

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02581144

Navigation